Welcome to our dedicated page for Waldencast news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast stock.
Waldencast plc operates as a global multi-brand beauty and wellness platform built around Obagi Medical and Milk Makeup. News about WALD commonly covers brand-level product launches, physician-dispensed skincare, cosmetics, suncare, and aesthetic offerings, including Obagi's advanced skincare products and Obagi® saypha® MagIQ™ hyaluronic acid filler.
Company updates also include quarterly and annual financial results, segment performance, channel and distribution developments, clinical-evidence collaborations for aesthetic products, supply-chain and credit-facility actions, and governance or reporting matters tied to financial restatements, internal control over financial reporting, and regulatory review.
Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results on Tuesday, May 21, 2024, before the U.S. stock market opens. The company will hold a conference call at 8:30am ET on the same day to discuss the results.
Investors and analysts can join the call by dialing (877) 704-4453, or (201) 389-0920 for international callers. The earnings call will also be webcast live on the company's investor relations website, where a replay will be available for 90 days.
Waldencast plc, a global multi-brand beauty and wellness platform, will participate in the CreatorIQ Connect Europe conference in London on May 2, 2024. Founder and CEO Michel Brousset will discuss building legacy brands with industry leaders. The event aims to explore creator marketing strategies in the beauty industry.
Waldencast plc reported a successful fiscal year 2023 with net revenue of $218.1 million, a 15.3% increase from 2022. Group combined comparable revenue reached $212.5 million, and adjusted EBITDA improved to $24.4 million. Obagi Skincare saw revenue growth excluding Southeast Asia, while Milk Makeup excelled with revenue of $100.5 million. The company expects a 20% growth in Q1 2024 and an expansion in adjusted EBITDA margin for FY2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.